Pharma Execs Can't Bolster PwC Row Over Tax Bill

Law360, London (June 2, 2021, 2:29 PM BST) -- A London court has prevented three pharmaceutical executives from expanding their bid to force PwC to pick up their tax bill after the audit firm's tax scheme came under attack by HM Revenue and Customs, ruling on Wednesday that new allegations cannot be added.

Lesley Anderson QC, sitting as a judge at the High Court, upheld findings that barred the men from bolstering their lawsuit against PricewaterhouseCoopers LLP and Landwell, a former law firm, in connection with a failed tax plan.

HMRC hit the men with a hefty tax bill after their companies paid out £24 million ($34 million) in bonuses...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!